Overweight and obesity in adults and risk of renal cell carcinoma in Canada

Sozial- und Praventivmedizin

Volumn 48, Issue 3, 2003, Pages 178-185

  Hu, Jinfu ^a   Mao, Yang ^a   White, Kathy ^b   Paulse, Bertha ^c   Dewar, Ron ^c   Dryer, Dagny ^c   Kreiger, Nancy ^c   Whittaker, Heather ^c   Robson, Diane ^c   Fincham, Shirley ^c   Le, Nhu ^c  

^a CANADIAN INSTITUTES OF HEALTH RESEARCH   (Canada)

^b STATISTICS CANADA   (Canada)

^c NONE

Author keywords

Body mass index; Logistic regression; Odds ratio; Renal cell carcinoma

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CANADA; CANCER RISK; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEEDING BEHAVIOR; FEMALE; GENDER; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; OCCUPATION; QUESTIONNAIRE; SMOKING HABIT; SOCIAL CLASS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; BODY MASS INDEX; CANADA; CARCINOMA, RENAL CELL; CAUSALITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; POPULATION SURVEILLANCE; RISK;

EID: 0038044919     PISSN: 03038408     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00038-003-2046-2     Document Type: Article

References (43)

1. Asal NR, Risser DR, Kadamani S, Geyer JR, Lee ET, Cherng N (1988). Risk factors in renal cell carcinoma. 1, Methodology, demographics, tobacco, beverage use, and obesity. Cancer Detect Prev 11: 359-77.
2. Bergstrom A, Hsieh CC, Lindblad P, Lu CM, Cook NR, Wolk A (2001a). Obesity and renal cell cancer - a quantitative review. Br J Cancer 85: 984-90.
3. Bergstrom A, Pisani P, Tenet V, Wolk A, Adami HO (2001b). Overweight as an avoidable cause of cancer in Europe. Int J Cancer 91: 421-30.
4. Block G, Hartman AM, Dresser CM, et al. (1986). A data-based approach to diet questionnaire design and testing. Am J Epidemiol 124: 453-69.
5. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW (1999). Body mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341: 1097-105.
6. Chow WH, Gridley G, Fraumeni JF Jr, Jarvholm B (2000). Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med 343: 1305-11.
7. Chow WH, McLaughlin JK, Mandel JS, Blot WJ, Niwa S, Fraumeni JF Jr (1995). Reproductive factors and the risk of renal cell cancer among women. Int J Cancer 60: 321-4.
8. Chow WH, McLaughlin JK, Mandel JS, Wacholder S, Niwa S, Fraumeni JF Jr (1996). Obesity and risk of renal cell cancer. Cancer Epidemiol Biomarkers Prev 5: 17-21.
9. Cohen PG (1999).The hypogonadal-obesity cycle: role of aromatase in modulating the testosterone-estradiol shunt - a major factor in the genesis of morbid obesity. Med Hypotheses 52: 49-51.
10. Cortes-Vizcaino V, Lombart-Bosch A (1993). Estrogen and progesterone receptors in the diethyl-stilbestrol-induced kidney neoplasms of the Syrian golden hamster: correlation with histopatholpogy and tumoral stages. Carcinogenesis 14: 1215-9.
11. Gago-Dominguez M, Castelao JE, Yuan JM, Ross RK, Yu MC (1999). Increased risk of renal cell carcinoma subsequent to hysterectomy. Cancer Epidemiol Biomarkers Prev 8: 999-1003.
12. Heath CW Jr, Lally CA, Calle EE, McLaughlin K. Thun MJ (1997). Hypertension, diuretics, and antihypertensive medications as possible risk factors for renal cell cancer. Am J Epidemiol 145: 607-13.
13. Hodgson AV, Ayala-Torres S, Thompson EB, Liehr JG (1998). Estrogen-induced microsatellite DNA alterations are associated with Syrian hamster kidney tumorigenesis. Carcinogenesis 19: 2169-72.
14. Hsiech CC, Signorello LB, Lipworth L, Lagiou P, Mantzoros CS, Trichopoulos D (1998). Predictors of sex hormone levels among the elderly: a study in Greece. J Clin Epidemiol 51: 837-41.
15. IARC (2002). Weight control and physical activity. Lyon: IARC Press. (IARC handbooks of cancer prevention: vol. 6).
16. Jakse G, Muller-Holzner E (1988). Hormone receptors in renal cancer: an overview. Semin Surg Oncol 4: 161-4.
17. Kalin MF, Zumoff B (1990). Sex hormones and coronary disease: a review of the clinical studies. Steroids 55: 330-52.
18. Kirkman H (1959). Estrogen-induced tumors of the kidney in Syrian hamsters. Nat Cancer Inst Monogr 1: 1-9.
19. Kuskowska-Wolk A, Karlsson P, Stolt M, Rossner S (1989). The predictive validity of body mass index based on self-reported weight and height. Int J Obes 13: 441-53.
20. Lindblad P, Mellemgaard A, Schlehofer B, et al. (1995). International renal cell study. 5, Reproductive factors, gynecologic operations and exogenous hormones. Int J Cancer 61: 192-8.
21. Le Marchand L, Yoshizawa CN, Nomura AM (1988). Validation of body size information on driver's licenses. Am J Epidemiol 128: 874-7.
22. Liu S, Semenciw R, Morrison H, Schanzer D, Mao Y (1997). Kidney cancer in Canada: the rapidly increasing incidence of adenocarcinoma in adults and seniors. Can J Public Health 88: 99-104.
23. McCredie M, Stewart JH (1992). Risk factors for kidney cancer in New South Wales, Australia. 2, Urologic disease, hypertension, obesity, and hormonal factors. Cancer Causes Control 3: 323-31.
24. McLaughlin JK, Chow WH, Mandel JS, et al. (1995). International renal-cell cancer study. 8, Role of diuretics, other anti-hypertensive medications and hypertension. Int J Cancer 63: 216-21.
25. McLaughlin JK, Lipworth L (2000). Epidemiologic aspects of renal cell cancer. Semin Oncol 27: 115-23.
26. McLaughlin JK, Mandel JS, Blot WJ, Schuman LM, Mehl ES, Fraumeni JF (1984). J Natl Cancer Inst 72: 275-84.
27. Mellemgaard A, Engholm G, McLaughlin JK, Olsen JH (1994b). Risk factors for renal cell carcinoma in Denmark. 3, Role of weight, physical activity and reproductive factors. Int J Cancer 56: 66-71.
28. Mellemgaard A, Lindblad P, Schlehofer B, et al. (1995). International renal cell cancer study. 3, Role of weight, height, physical activity, and use of amphetamines. Int J Cancer 60: 350-4.
29. Mellemgaard A, Niwa S, Mehl ES, et al. (1994a). Risk factors for renal cell carcinoma in Denmark: role of medication and medical history. Int J Epidemiol 23: 923-30.
30. Moller H, Mellemgaard A, Lindvig K, Olsen JH (1994). Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 30A: 344-50.
31. Percy C, Holten VV, Muir C (1990). International classification of diseases for oncology. 2nd ed. Geneva: World Health Organization.
32. Riva P, Alboni S, Bonati M, et al. (1992). Endocrine aspects of obesity. In: Belfiore F, Jean-renaud B, Papalia D, eds. Obesity: basic concepts and clinical aspects: frontiers in diabetes. Basel: Karger.
33. SAS System for Windows Release 6.12 (1996). Carey, NC: SAS Institute Inc.
34. Shapiro JA, Williams MA, Weiss NS, et al. (1999b). Hypertension, antihypertensive medication use, and risk of renal cell carcinoma. Am J Epidemiol 149: 521-30.
35. Shapiro JA, Williams MA, Weiss NS (1999a). Body mass index and risk of renal cell carcinoma. Epidemiology 10: 188-91.
36. Stevens J, Keil JE, Waid LR, Gazes PC (1990). Accuracy of current, 4-year, and 28-year self-reported body weight in an elderly population. Am J Epidemiol 132: 1156-413.
37. Stewart AL (1982). The reliability and validity of self-reported weight and height. J Chronic Dis 35: 295-309.
38. Stunkard AJ, Albaum JM (1981). The accuracy of self-reported weights. Am J Clin Nutr 34: 1593-9.
39. Tavani A, La Vecchia C (1997). Epidemiology of renal cell carcinoma. J Nephrol 10: 93-106.
40. Wolk A, Gridley G, Svensson M et al. (2001). A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 12: 13-21.
41. World Health Organization (2000). Obesity: preventing and managing the global epidemic. Geneva: World Health Organization. (Technical report series; No. 894).
42. Yu MC, Mack TM, Hanisch R, Cicioni C, and Henderson BE (1986). Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma. J Natl Cancer Inst 77: 351-6.
43. Yuan JM, Castelao JE, Gago-Dominguez M, Ross RK, Yu MC (1998). Hypertension, obesity and their medications in relation to renal cell carcinoma. Br J Cancer 77: 1508-13.